In today’s recent session, 2.51 million shares of the Iovance Biotherapeutics Inc (NASDAQ:IOVA) have been traded, and its beta is 1.07. Most recently the company’s share price was $3.31, and it changed around -$0.19 or -5.57% from the last close, which brings the market valuation of the company to $1.10B. IOVA at last check was trading at a discount to its 52-week high of $14.23, offering almost -329.91% off that amount. The share price’s 52-week low was $2.70, which indicates that the recent value has risen by an impressive 18.43% since then.
Iovance Biotherapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.31. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 1 recommended IOVA as a Hold, whereas 8 deemed it a Buy, and 0 rated it as Underweight.
Iovance Biotherapeutics Inc (NASDAQ:IOVA) trade information
Instantly IOVA has been showing red trend so far today with a performance of -5.57% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 3.73 on recent trading dayincreased the stock’s daily price by 11.26%. The company’s shares are currently down -55.34% year-to-date, but still down -7.16% over the last five days. On the other hand, Iovance Biotherapeutics Inc (NASDAQ:IOVA) is 10.17% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 44.83% from its current value. Analyst projections state that IOVA is forecast to be at a low of $6 and a high of $6.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 4.17%.
IOVA Dividends
Iovance Biotherapeutics Inc’s next quarterly earnings report is expected to be released in June.
PERCEPTIVE ADVISORS LLC, with 9.1052% or 25.93 million shares worth $207.98 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 8.61 shares worth $28.67 million, making up 2.58% of all outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held roughly 7.28 shares worth around $24.25 million, which represents about 2.18% of the total shares outstanding.
